Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

19/06/2014 ALBA synchrotron welcomes the one thousandth researcher 12/06/2014 € 1.365 billion of foreign investment in the Catalan industry in 2013 03/06/2014 Barcelona Synchroton Park booth at the BioKorea 2014 exhibition in Seoul 27/05/2014 The new Barcelona Synchrotron Park bus shuttle completes its first six months 20/05/2014 SENER opens in the Barcelona Synchrotron Park its new corporate headquarters in Catalonia 15/05/2014 MATGAS, Air Products' leading R&D centre worldwide
40 41 42 43 44 45 46 47 48 49